Novaremed AG
www.novaremed.comNovaremed AG is a clinical-stage Swiss biopharmaceutical company, HQ in Basel, Switzerland, with a subsidiary in Israel. Novaremed is developing an orally active, first-in-class, small molecule (NRD.E1), with a novel mechanism of action, to treat Diabetic Neuropathic Pain.
Read more
Novaremed AG is a clinical-stage Swiss biopharmaceutical company, HQ in Basel, Switzerland, with a subsidiary in Israel. Novaremed is developing an orally active, first-in-class, small molecule (NRD.E1), with a novel mechanism of action, to treat Diabetic Neuropathic Pain.
Read more
Country
City (Headquarters)
Basel
Industry
Employees
1-10
Founded
2017
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Executive Chairman of the Board of Directors
Email ****** @****.comPhone (***) ****-****Head of Biometry
Email ****** @****.comPhone (***) ****-****
Technologies
(1)
Reach decision makers at Novaremed AG
Free credits every month!
Novaremed AG FAQ
Basel, Switzerland
Biotechnology Research
